sk&f 105685 has been researched along with omega-n-methylarginine in 1 studies
| Studies (sk&f 105685) | Trials (sk&f 105685) | Recent Studies (post-2010) (sk&f 105685) | Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) |
|---|---|---|---|---|---|
| 22 | 0 | 0 | 4,411 | 344 | 336 |
| Protein | Taxonomy | sk&f 105685 (IC50) | omega-n-methylarginine (IC50) |
|---|---|---|---|
| Neutrophil elastase | Homo sapiens (human) | 0.3 | |
| Proteinase-activated receptor 1 | Homo sapiens (human) | 0.0018 | |
| Nitric oxide synthase, endothelial | Bos taurus (cattle) | 7 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.9489 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 3.3983 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 7.5 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 2.3 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 2.9252 | |
| Collagenase 3 | Homo sapiens (human) | 0.3 | |
| Nitric oxide synthase, brain | Mus musculus (house mouse) | 4.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badger, AM; Bugelski, PJ; Kaplan, JM; Newman-Tarr, T; Olivera, DL; Ruggieri, EV | 1 |
1 other study(ies) available for sk&f 105685 and omega-n-methylarginine
| Article | Year |
|---|---|
Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agent.
Topics: Animals; Arginine; Arthritis; Concanavalin A; Cyclosporine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Indomethacin; Interleukin-2; Lymphocyte Activation; Male; omega-N-Methylarginine; Polyenes; Rats; Rats, Inbred Lew; Sirolimus; Spiro Compounds; Spleen; Time Factors; Tumor Cells, Cultured | 1991 |